Free Trial

Corpay (CPAY) Stock Forecast & Price Target

Corpay logo
$308.95 +3.47 (+1.14%)
As of 03:58 PM Eastern

Corpay - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
11

Based on 14 Wall Street analysts who have issued ratings for Corpay in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, 10 have given a buy rating, and 1 has given a strong buy rating for CPAY.

Consensus Price Target

$400.38
29.60% Upside
According to the 14 analysts' twelve-month price targets for Corpay, the average price target is $400.38. The highest price target for CPAY is $445.00, while the lowest price target for CPAY is $345.00. The average price target represents a forecasted upside of 29.60% from the current price of $308.95.
Get the Latest News and Ratings for CPAY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corpay and its competitors.

Sign Up

CPAY Analyst Ratings Over Time

TypeCurrent Forecast
4/14/24 to 4/14/25
1 Month Ago
3/15/24 to 3/15/25
3 Months Ago
1/15/24 to 1/14/25
1 Year Ago
4/15/23 to 4/14/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$400.38$399.71$377.50$365.50
Forecasted Upside29.60% Upside18.21% Upside5.40% Upside21.87% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Remove Ads

CPAY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CPAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corpay Stock vs. The Competition

TypeCorpayBusiness Services CompaniesS&P 500
Consensus Rating Score
2.86
2.72
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside29.60% Upside336.52% Upside25.81% Upside
News Sentiment Rating
Very Positive News

See Recent CPAY News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/14/2025Barclays
3 of 5 stars
Ramsey El-Assal
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$440.00 ➝ $400.00+28.88%
2/6/2025Raymond James
4 of 5 stars
John Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$434.00 ➝ $417.00+5.80%
2/6/2025Royal Bank of Canada
4 of 5 stars
Daniel Perlin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$354.00 ➝ $400.00+1.94%
2/6/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sanjay Sakhrani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$415.00 ➝ $445.00+14.12%
2/6/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Faucette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$350.00 ➝ $380.00-2.25%
1/16/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrew Bauch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$340.00 ➝ $375.00+0.37%
1/14/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$430.00+20.05%
1/8/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Peller
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$420.00+20.85%
12/13/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$400.00 ➝ $440.00+21.78%
10/16/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$375.00 ➝ $425.00+23.19%
10/15/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$344.00 ➝ $375.00+9.40%
8/20/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$327.00 ➝ $353.00+21.24%
8/8/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Jeffrey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/25/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$350.00 ➝ $345.00+28.65%
4/4/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$355.00 ➝ $376.00+18.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:36 AM ET.


CPAY Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Corpay is $400.38, with a high forecast of $445.00 and a low forecast of $345.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corpay in the last twelve months. There are currently 3 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CPAY shares.

According to analysts, Corpay's stock has a predicted upside of 29.60% based on their 12-month stock forecasts.

Corpay has been rated by research analysts at Barclays, Citigroup, Keefe, Bruyette & Woods, Morgan Stanley, Raymond James, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Analysts like Corpay more than other "business services" companies. The consensus rating score for Corpay is 2.86 while the average consensus rating score for "business services" companies is 2.72. Learn more on how CPAY compares to other companies.


This page (NYSE:CPAY) was last updated on 4/14/2025 by MarketBeat.com Staff
From Our Partners